Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.
At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.
As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.
To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.
ESSENTIAL JOB FUNCTIONS:
- Prepare monthly/quarterly journal entries for prepaids, depreciation of fixed assets, capitalized software, and commercial and G&A accruals.
- Prepare monthly reconciliations for various accounts, including but not limited to bank reconciliations, prepaids, fixed assets, long-term assets, G&A and commercial accrued contracts, software capitalization, etc.
- Collaborate with business owners and functional leaders to obtain contracts and project progress and information to ensure timely and accurate accruals.
- Analyze contracts and collaborate with functional owners to appropriately capture capitalized software and fixed assets.
- Prepare monthly and quarterly variance analyses for various accounts and projects.
- Perform monthly close activities such as preparing monthly trial balance and reporting.
- Review invoice and purchase order coding for assigned departments.
- Prepare and submit property tax filing for various locations and ad hoc reporting.
- Ensure accuracy and compliance with GAAP and Sarbanes Oxley policy and procedures.
- Support financial and SOX reviews and audits - gather information, prepare schedules as needed.
- Responsible for quarterly related party updates and support, including related party inquiries, related party memo update, and transactional JE’s and analysis.
- Responsible for overseeing and reviewing the R&D by location reporting for taxes and census reporting.
- Perform other duties and ad hoc projects, as assigned, to support the Finance department.
JOB SPECIFICATIONS:
- Bachelor’s degree in accounting, or other related discipline, or the equivalent knowledge and experience required.
- A minimum of 5 years’ relevant accounting experience, preferably in a combination of the following monthly close process, bank reconciliations, balance sheet reconciliations, contract accruals
- Excellent communication and people skills and the ability to interface with various levels of co-workers, upper management, and external customers while maintaining a high degree of confidentiality.
- Experience working in publicly traded company and life science industry preferred.
- Knowledge of US GAAP and internal control principles for a public corporation.
- ERP experience required; experience with NetSuite, Blackline, Coupa and Concur preferred.
- Skilled in the use of Microsoft Office Suite with intermediate to advanced Excel skills.
- Detail oriented with good analytical skills.
- Strong time management skills and ability to independently organize multiple tasks of varying priorities and meet critical deadlines in a fast-paced environment.
- Ability to work in team environment and willing to assist other team members to achieve team goals and objectives.
The base range for this role is $100,000 - $122,000. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.
#LI-RM1
Kura’s Values that are used for candidate selection and performance assessments:
- We work as one for patients
- We are goal-focused and deliver with excellence
- We are science-driven courageous innovators
- We strive to bring out the best in each other and ourselves
The Kura Package
- Career advancement/ development opportunities
- Competitive comp package
- Bonus
- 401K + Employer contributions
- Generous stock options
- ESPP Plan
- 20 days of PTO to start
- 18 Holidays (Including Summer & Winter Break)
- Generous Benefits Package with a variety of plans available with a substantial employer match
- Paid Paternity/Maternity Leave
- In-Office Catered lunches
- Home Office Setup
- Lifestyle Spending Stipend
- Commuter Stipend (Boston Office)
- Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!
Kura Oncology is a commercial-stage biopharmaceutical company committed to discovering and developing innovative precision medicines to help patients with cancer lead better, longer lives.
Through our deep understanding of cancer biology and decades of experience in precision oncology, we are studying the underlying causes of treatment resistance. This enables us to design smart combination regimens with other cancer therapies to target tumors from multiple directions, with the goal of improving long-term clinical benefit.
Kura developed and is commercializing KOMZIFTI™ (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.
Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
If you are a California resident, please see the attached Privacy Notice CA Privacy Notice
Skills Required
- Bachelor's degree in accounting or related discipline (or equivalent experience)
- Minimum of 5 years relevant accounting experience (monthly close, reconciliations, accruals)
- ERP experience
- Experience with NetSuite
- Experience with BlackLine
- Experience with Coupa
- Experience with Concur
- Knowledge of US GAAP and internal control principles for a public corporation
- Experience with Sarbanes-Oxley (SOX) compliance and supporting audits
- Intermediate to advanced Excel skills and proficiency with Microsoft Office
- Experience preparing monthly/quarterly journal entries for prepaids, depreciation, capitalized software, and accruals
- Experience preparing monthly reconciliations (bank, prepaids, fixed assets, long-term assets, accrued contracts)
- Ability to analyze contracts and capture capitalized software and fixed assets
- Experience with property tax filing and related reporting
- Experience managing related-party updates, inquiries, and related JEs/analysis
- Excellent communication, interpersonal, and confidentiality skills
- Detail oriented with strong analytical skills
- Strong time management and ability to prioritize multiple tasks to meet deadlines
- Ability to work collaboratively in a team environment
- Experience working in a publicly traded company and life sciences industry
What We Do
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Our pipeline includes tipifarnib, a farnesyl transferase inhibitor, currently in a registration-directed clinical trial and KO-539, a menin-MLL inhibitor, currently in a Phase 1/2A clinical trial. For additional information, please visit our website at www.kuraoncology.com.
